Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT.
This cross-sectional study describes health outcomes attributed to recent use of psilocybin, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), ibogaine, and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a nationally representative survey of US adults.
- Authors
- Simonsson O, Bradley M, Black JC, Rockhill KM, Monte AA, Hendricks PS
- Journal
- JAMA network open
- Published
- 2026-09-01
- DOI
- 10.1001/jamanetworkopen.2026.36756
- PMID
- 42809289
- Content type
- Paper
- Authority
- Academic
Abstract
This cross-sectional study describes health outcomes attributed to recent use of psilocybin, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), ibogaine, and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a nationally representative survey of US adults.
Citation
Simonsson O, Bradley M, Black JC, Rockhill KM, Monte AA, Hendricks PS (2026) Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT.. JAMA network open. doi:10.1001/jamanetworkopen.2026.36756
DOI: 10.1001/jamanetworkopen.2026.36756
Indexed by the DMT Code Research Bibliography, an open, stance scored library (CC-BY-4.0).